{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:44:36Z","timestamp":1789469076272,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s40257-026-01053-y","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T16:32:15Z","timestamp":1783614735000},"page":"959-975","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Systematic Review of Factors Influencing Adult Adherence to Topical Medications in Atopic Dermatitis"],"prefix":"10.1007","volume":"27","author":[{"given":"Stacey N.","family":"Giuffre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila R.","family":"Marquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlyn B.","family":"Dagenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Gawey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7510-9428","authenticated-orcid":false,"given":"Vivian Y.","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"issue":"7","key":"1053_CR1","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/all.12619","volume":"70","author":"CG Mortz","year":"2015","unstructured":"Mortz CG, Andersen KE, Dellgren C, Barington T, Bindslev-Jensen C. Atopic dermatitis from adolescence to adulthood in the TOACS cohort: prevalence, persistence and comorbidities. Allergy. 2015;70(7):836\u201345. https:\/\/doi.org\/10.1111\/all.12619. (PubMed PMID: 25832131).","journal-title":"Allergy"},{"issue":"6","key":"1053_CR2","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/jamadermatol.2013.10271","volume":"150","author":"JS Margolis","year":"2014","unstructured":"Margolis JS, Abuabara K, Bilker W, Hoffstad O, Margolis DJ. Persistence of mild to moderate atopic dermatitis. JAMA Dermatol. 2014;150(6):593\u2013600. https:\/\/doi.org\/10.1001\/jamadermatol.2013.10271. (PubMed PMID: 24696036; PubMed Central PMCID: PMC4352328).","journal-title":"JAMA Dermatol"},{"issue":"1","key":"1053_CR3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jaad.2022.12.029","volume":"89","author":"R Sidbury","year":"2023","unstructured":"Sidbury R, Alikhan A, Bercovitch L, Cohen DE, Darr JM, Drucker AM, et al. Guidelines of care for the management of atopic dermatitis in adults with topical therapies. J Am Acad Dermatol. 2023;89(1):e1-20. https:\/\/doi.org\/10.1016\/j.jaad.2022.12.029. (PubMed PMID: 36641009).","journal-title":"J Am Acad Dermatol"},{"key":"1053_CR4","unstructured":"World Health Organization. Adherence to long-term therapies\u202f: evidence for action [Internet]. World Health Organization; 2003. https:\/\/iris.who.int\/handle\/10665\/42682. Cited 16 Aug 2025."},{"issue":"372","key":"1053_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"29","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;29(372):n71. https:\/\/doi.org\/10.1136\/bmj.n71. (PubMed PMID: 33782057).","journal-title":"BMJ"},{"key":"1053_CR6","unstructured":"JBI manual for evidence synthesis Nov 2024."},{"issue":"23","key":"1053_CR7","first-page":"161","volume":"1","author":"R Huynh","year":"2015","unstructured":"Huynh R, Wong H, Aw D, Toh M. Adherence to topical corticosteroids and moisturisers in adults with endogenous eczema in Singapore. Hong Kong J Dermatol Venereol. 2015;1(23):161\u201374.","journal-title":"Hong Kong J Dermatol Venereol."},{"issue":"3","key":"1053_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jdermsci.2015.05.010","volume":"79","author":"H Murota","year":"2015","unstructured":"Murota H, Takeuchi S, Sugaya M, Tanioka M, Onozuka D, Hagihara A, et al. Characterization of socioeconomic status of Japanese patients with atopic dermatitis showing poor medical adherence and reasons for drug discontinuation. J Dermatol Sci. 2015;79(3):279\u201387. https:\/\/doi.org\/10.1016\/j.jdermsci.2015.05.010. (PubMed PMID: 26255207).","journal-title":"J Dermatol Sci"},{"issue":"1","key":"1053_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/cod.12206","volume":"71","author":"A Mollerup","year":"2014","unstructured":"Mollerup A, Veien NK, Johansen JD. An analysis of gender differences in patients with hand eczema\u2014everyday exposures, severity, and consequences. Contact Dermatitis. 2014;71(1):21\u201330. https:\/\/doi.org\/10.1111\/cod.12206. (PubMed PMID: 24618009).","journal-title":"Contact Dermatitis"},{"issue":"4","key":"1053_CR10","first-page":"135","volume":"32","author":"M Starbek Zorko","year":"2023","unstructured":"Starbek Zorko M, Benko M, Raku\u0161a M, Prunk ZT. Evaluation of corticophobia in patients with atopic dermatitis and psoriasis using the TOPICOP\u00a9 score. Acta Dermatovenerol Alp Pannonica Adriat. 2023;32(4):135\u20139 (PubMed PMID: 38126095).","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat."},{"issue":"5","key":"1053_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.adengl.2013.04.004","volume":"104","author":"A Torrelo","year":"2013","unstructured":"Torrelo A, Ortiz J, Alomar A, Ros S, Pedrosa E, Cuervo J. Health-related quality of life, patient satisfaction, and adherence to treatment in patients with moderate or severe atopic dermatitis on maintenance therapy: the CONDA-SAT study. Actas Dermosifiliogr. 2013;104(5):409\u201317. https:\/\/doi.org\/10.1016\/j.adengl.2013.04.004. (PubMed PMID: 23665434).","journal-title":"Actas Dermosifiliogr"},{"issue":"5","key":"1053_CR12","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1177\/12034754231188435","volume":"27","author":"C Kontzias","year":"2023","unstructured":"Kontzias C, Prajapati S, Feldman SR. Greater disease severity and reduced quality of life are not associated with treatment adherence in atopic patients with xerosis. J Cutan Med Surg. 2023;27(5):534\u20136. https:\/\/doi.org\/10.1177\/12034754231188435. (PubMed PMID: 37493272).","journal-title":"J Cutan Med Surg"},{"key":"1053_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/894258","volume":"2010","author":"V Pena-Robichaux","year":"2010","unstructured":"Pena-Robichaux V, Kvedar JC, Watson AJ. Text messages as a reminder aid and educational tool in adults and adolescents with atopic dermatitis: a pilot study. Dermatol Res Pract. 2010;2010:894258. https:\/\/doi.org\/10.1155\/2010\/894258. (PubMed PMID: 20885940; PubMed Central PMCID: PMC2946611).","journal-title":"Dermatol Res Pract"},{"issue":"3","key":"1053_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/cod.13448","volume":"82","author":"D Erdil","year":"2020","unstructured":"Erdil D, Koku Aksu AE, Falay G\u00fcr T, G\u00fcrel MS. Hand eczema treatment: change behaviour with text messaging, a randomized trial. Contact Dermatitis. 2020;82(3):153\u201360. https:\/\/doi.org\/10.1111\/cod.13448. (PubMed PMID: 31794053).","journal-title":"Contact Dermatitis"},{"issue":"3","key":"1053_CR15","first-page":"205","volume":"102","author":"N Okwundu","year":"2018","unstructured":"Okwundu N, Cardwell LA, Cline A, Unrue EL, Richardson IM, Feldman SR. Topical corticosteroids for treatment-resistant atopic dermatitis. Cutis. 2018;102(3):205\u20139 (PubMed PMID: 30372711).","journal-title":"Cutis"},{"issue":"5","key":"1053_CR16","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1177\/12034754231188433","volume":"27","author":"S Prajapati","year":"2023","unstructured":"Prajapati S, Kontzias C, Feldman SR. The impact accountability has on adherence to moisturizer treatment in atopic patients with xerosis. J Cutan Med Surg. 2023;27(5):538\u20139. https:\/\/doi.org\/10.1177\/12034754231188433. (PubMed PMID: 37489931).","journal-title":"J Cutan Med Surg"},{"issue":"10","key":"1053_CR17","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.36849\/JDD.6280","volume":"21","author":"S Snyder","year":"2022","unstructured":"Snyder S, Collins A, Cline A, Bashyam A, Unrue E, Feldman S, et al. Measuring and improving adherence to crisaborole 2% ointment in patients with atopic dermatitis. J Drugs Dermatol JDD. 2022;21(10):1043\u20138. https:\/\/doi.org\/10.36849\/JDD.6280. (PubMed PMID: 36219061).","journal-title":"J Drugs Dermatol JDD."},{"issue":"4","key":"1053_CR18","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/j.1365-2133.2011.10449.x","volume":"165","author":"H Aubert-Wastiaux","year":"2011","unstructured":"Aubert-Wastiaux H, Moret L, Le Rhun A, Fontenoy AM, Nguyen JM, Leux C, et al. Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency. Br J Dermatol. 2011;165(4):808\u201314. https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10449.x. (PubMed PMID: 21671892).","journal-title":"Br J Dermatol"},{"issue":"10","key":"1053_CR19","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1111\/1346-8138.16054","volume":"48","author":"K Kamei","year":"2021","unstructured":"Kamei K, Hirose T, Yoshii N, Tanaka A. Burden of illness, medication adherence, and unmet medical needs in Japanese patients with atopic dermatitis: a retrospective analysis of a cross-sectional questionnaire survey. J Dermatol. 2021;48(10):1491\u20138. https:\/\/doi.org\/10.1111\/1346-8138.16054. (PubMed PMID: 34231235; PubMed Central PMCID: PMC9291885).","journal-title":"J Dermatol"},{"issue":"3","key":"1053_CR20","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1159\/000018495","volume":"201","author":"M Fukaya","year":"2000","unstructured":"Fukaya M. Why do patients with atopic dermatitis refuse to apply topical corticosteroids? Dermatol Basel Switz. 2000;201(3):242\u20135. https:\/\/doi.org\/10.1159\/000018495. (PubMed PMID: 11096196).","journal-title":"Dermatol Basel Switz."},{"issue":"6","key":"1053_CR21","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.jaad.2020.02.079","volume":"83","author":"E Choi","year":"2020","unstructured":"Choi E, Tan KW, Tang F, Tan C, Chandran NS. Efficacy of targeted education in reducing topical steroid phobia: a randomized clinical trial. J Am Acad Dermatol. 2020;83(6):1681\u20137. https:\/\/doi.org\/10.1016\/j.jaad.2020.02.079. (PubMed PMID: 32171815).","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1053_CR22","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1159\/000446068","volume":"232","author":"SM M\u00fcller","year":"2016","unstructured":"M\u00fcller SM, Tomaschett D, Euler S, Vogt DR, Herzog L, Itin P. Topical corticosteroid concerns in dermatological outpatients: a cross-sectional and interventional study. Dermatol Basel Switz. 2016;232(4):444\u201352. https:\/\/doi.org\/10.1159\/000446068. (PubMed PMID: 27322385).","journal-title":"Dermatol Basel Switz."},{"issue":"4","key":"1053_CR23","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/cod.12243","volume":"71","author":"A Mollerup","year":"2014","unstructured":"Mollerup A, Veien NK, Johansen JD. Effectiveness of the Healthy Skin Clinic\u2014a randomized clinical trial of nurse-led patient counselling in hand eczema. Contact Dermatitis. 2014;71(4):202\u201314. https:\/\/doi.org\/10.1111\/cod.12243. (PubMed PMID: 24766387).","journal-title":"Contact Dermatitis"},{"issue":"3","key":"1053_CR24","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1159\/000357523","volume":"228","author":"MAM Corti","year":"2014","unstructured":"Corti MAM, Stirnimann R, Borradori L, Simon D. Effects of systematic patient education in skin care and protection in a hand eczema clinic. Dermatol Basel Switz. 2014;228(3):220\u20134. https:\/\/doi.org\/10.1159\/000357523. (PubMed PMID: 24776632).","journal-title":"Dermatol Basel Switz."},{"issue":"4","key":"1053_CR25","first-page":"208","volume":"86","author":"BA Yentzer","year":"2010","unstructured":"Yentzer BA, Ade RA, Fountain JM, Clark AR, Taylor SL, Borgerding E, et al. Improvement in treatment adherence with a 3-day course of fluocinonide cream 0.1% for atopic dermatitis. Cutis. 2010;86(4):208\u201313 (PubMed PMID: 21140931).","journal-title":"Cutis"},{"issue":"10","key":"1053_CR26","doi-asserted-by":"publisher","first-page":"20029","DOI":"10.5070\/D31910020029","volume":"19","author":"E Hix","year":"2013","unstructured":"Hix E, Gustafson CJ, O\u2019Neill JL, Huang K, Sandoval LF, Harrison J, et al. Adherence to a five day treatment course of topical fluocinonide 0.1% cream in atopic dermatitis. Dermatol Online J. 2013;19(10):20029 (PubMed PMID: 24139369).","journal-title":"Dermatol Online J"},{"issue":"1","key":"1053_CR27","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jaad.2008.09.031","volume":"60","author":"R Wilson","year":"2009","unstructured":"Wilson R, Camacho F, Clark AR, Young T, Inabinet R, Yentzer BA, et al. Adherence to topical hydrocortisone 17-butyrate 0.1% in different vehicles in adults with atopic dermatitis. J Am Acad Dermatol. 2009;60(1):166\u20138. https:\/\/doi.org\/10.1016\/j.jaad.2008.09.031.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"1053_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/cod.14447","volume":"90","author":"DM Gregersen","year":"2024","unstructured":"Gregersen DM, Peckruhn M, Breternitz-Gruhne M, Schiller I, Schumacher U, Franke L, et al. Cream versus ointment: randomized single-blinded study on the adherence to treatment with topical methylprednisolone aceponate. Contact Dermatitis. 2024;90(2):161\u20138. https:\/\/doi.org\/10.1111\/cod.14447. (PubMed PMID: 37960922).","journal-title":"Contact Dermatitis"},{"issue":"4","key":"1053_CR29","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1080\/09546634.2021.1940810","volume":"33","author":"C Ervin","year":"2022","unstructured":"Ervin C, Crawford R, Evans E, Feldman SR, Zeichner J, Zielinski MA, et al. Patient and caregiver preferences on treatment attributes for atopic dermatitis. J Dermatol Treat. 2022;33(4):2225\u201333. https:\/\/doi.org\/10.1080\/09546634.2021.1940810. (PubMed PMID: 34264145).","journal-title":"J Dermatol Treat"},{"issue":"1","key":"1053_CR30","doi-asserted-by":"publisher","first-page":"2215356","DOI":"10.1080\/09546634.2023.2215356","volume":"34","author":"K Myers","year":"2023","unstructured":"Myers K, Silverberg JI, Parasuraman S, Pierce A, Eichenfield LF, Poulos C. Treatment preferences among patients with mild-to-moderate atopic dermatitis. J Dermatol Treat. 2023;34(1):2215356. https:\/\/doi.org\/10.1080\/09546634.2023.2215356. (PubMed PMID: 37259544).","journal-title":"J Dermatol Treat"},{"issue":"2","key":"1053_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/09546634.2017.1350256","volume":"29","author":"MY Yang","year":"2018","unstructured":"Yang MY, Jin H, Shim WH, Kim GW, Kim HS, Ko HC, et al. High rates of secondary non-adherence causes decreased efficacy of 0.1% topical tacrolimus in adult eczema patients: results from a multicenter clinical trial. J Dermatol Treat. 2018;29(2):129\u201334. https:\/\/doi.org\/10.1080\/09546634.2017.1350256.","journal-title":"J Dermatol Treat"},{"issue":"3","key":"1053_CR32","doi-asserted-by":"publisher","first-page":"162","DOI":"10.5114\/pdia.2014.40962","volume":"32","author":"R Jeziorkowska","year":"2015","unstructured":"Jeziorkowska R, Sysa-J\u0119drzejowska A, Samochocki Z. Topical steroid therapy in atopic dermatitis in theory and practice. Postepy Dermatol Alergol. 2015;32(3):162\u20136. https:\/\/doi.org\/10.5114\/pdia.2014.40962. (PubMed PMID: 26161055; PubMed Central PMCID: PMC4495104).","journal-title":"Postepy Dermatol Alergol."},{"issue":"2","key":"1053_CR33","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1080\/09546634.2017.1358803","volume":"29","author":"KM Joergensen","year":"2018","unstructured":"Joergensen KM, Jemec GBE. Use of moisturizers among Danish atopic dermatitis patients-which perceived product characteristics associate with long-term adherence? J Dermatol Treat. 2018;29(2):116\u201322. https:\/\/doi.org\/10.1080\/09546634.2017.1358803. (PubMed PMID: 28782438).","journal-title":"J Dermatol Treat"},{"issue":"3","key":"1053_CR34","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1473-2165.2011.00568.x","volume":"10","author":"ZD Draelos","year":"2011","unstructured":"Draelos ZD. A clinical evaluation of the comparable efficacy of hyaluronic acid-based foam and ceramide-containing emulsion cream in the treatment of mild-to-moderate atopic dermatitis. J Cosmet Dermatol. 2011;10(3):185\u20138. https:\/\/doi.org\/10.1111\/j.1473-2165.2011.00568.x. (PubMed PMID: 21896129).","journal-title":"J Cosmet Dermatol"},{"issue":"1 Suppl","key":"1053_CR35","first-page":"13","volume":"88","author":"NS Trookman","year":"2011","unstructured":"Trookman NS, Rizer RL, Ho ET, Ford RO, Gotz V. The importance of vehicle properties to patients with atopic dermatitis. Cutis. 2011;88(1 Suppl):13\u20137 (PubMed PMID: 21919229).","journal-title":"Cutis"},{"issue":"6","key":"1053_CR36","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/j.jaad.2020.03.074","volume":"83","author":"AM Bashyam","year":"2020","unstructured":"Bashyam AM, Cuellar-Barboza A, Masicampo EJ, Feldman SR. Framing atopic dermatitis topical medication application site discomfort as a signal of efficacy improves willingness to continue use. J Am Acad Dermatol. 2020;83(6):1773\u20135. https:\/\/doi.org\/10.1016\/j.jaad.2020.03.074. (PubMed PMID: 32246967).","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1053_CR37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/09546630801955127","volume":"19","author":"L Waernulf","year":"2008","unstructured":"Waernulf L, Moberg C, Henriksson EW, Evengard B, Nyberg F. Patients\u2019 views on care and treatment after phototherapy for psoriasis and atopic eczema including a gender perspective. J Dermatolog Treat. 2008;19(4):233\u201340. https:\/\/doi.org\/10.1080\/09546630801955127.","journal-title":"J Dermatolog Treat"},{"issue":"6","key":"1053_CR38","first-page":"461","volume":"69","author":"RO McAlister","year":"2002","unstructured":"McAlister RO, Tofte SJ, Doyle JJ, Jackson A, Hanifin JM. Patient and physician perspectives vary on atopic dermatitis. Cutis. 2002;69(6):461\u20136 (PubMed PMID: 12078849).","journal-title":"Cutis"},{"issue":"1","key":"1053_CR39","first-page":"46","volume":"94","author":"WJ Eastman","year":"2014","unstructured":"Eastman WJ, Malahias S, Delconte J, DiBenedetti D. Assessing attributes of topical vehicles for the treatment of acne, atopic dermatitis, and plaque psoriasis. Cutis. 2014;94(1):46\u201353 (PubMed PMID: 25101344).","journal-title":"Cutis"},{"issue":"6","key":"1053_CR40","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.jaad.2024.07.1503","volume":"91","author":"MO Christensen","year":"2024","unstructured":"Christensen MO, Sieborg J, Nymand LK, Guttman-Yassky E, Ezzedine K, Schlapbach C, et al. Prevalence and clinical impact of topical corticosteroid phobia among patients with chronic hand eczema-Findings from the Danish Skin Cohort. J Am Acad Dermatol. 2024;91(6):1094\u2013103. https:\/\/doi.org\/10.1016\/j.jaad.2024.07.1503.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1053_CR41","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1046\/j.1365-2133.2000.03473.x","volume":"142","author":"CR Charman","year":"2000","unstructured":"Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol. 2000;142(5):931\u20136. https:\/\/doi.org\/10.1046\/j.1365-2133.2000.03473.x.","journal-title":"Br J Dermatol"},{"issue":"1","key":"1053_CR42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1684\/ejd.2011.1560","volume":"22","author":"A Torrelo","year":"2012","unstructured":"Torrelo A, Ortiz J, Alomar A, Ros S, Prieto M, Cuervo J. Atopic dermatitis: impact on quality of life and patients\u2019 attitudes toward its management. Eur J Dermatol. 2012;22(1):97\u2013105. https:\/\/doi.org\/10.1684\/ejd.2011.1560.","journal-title":"Eur J Dermatol"},{"issue":"10","key":"1053_CR43","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/1346-8138.14540","volume":"45","author":"HJ Jung","year":"2018","unstructured":"Jung HJ, Bae JY, Kim JE, Na CH, Park GH, Bae YI, et al. Survey of disease awareness, treatment behavior and treatment satisfaction in patients with atopic dermatitis in Korea: a multicenter study. J Dermatol. 2018;45(10):1172\u201380. https:\/\/doi.org\/10.1111\/1346-8138.14540.","journal-title":"J Dermatol"},{"issue":"4","key":"1053_CR44","first-page":"437","volume":"78","author":"CH Kew","year":"2023","unstructured":"Kew CH, Ahmad Basir KF, Low DW, Loh KC. Breaking through the steroid stigma: a single-centre study on topical corticosteroid perception and adherence in dermatology patients and caregivers. Med J Malaysia. 2023;78(4):437\u201344 (PubMed PMID: 37518909).","journal-title":"Med J Malaysia"},{"issue":"4","key":"1053_CR45","first-page":"416","volume":"6","author":"M Boguniewicz","year":"2007","unstructured":"Boguniewicz M, Abramovits W, Paller A, Whitaker-Worth DL, Prendergast M, Cheng JW, et al. A multiple-domain framework of clinical, economic, and patient-reported outcomes for evaluating benefits of intervention in atopic dermatitis. J Drugs Dermatol JDD. 2007;6(4):416\u201323 (PubMed PMID: 17668539).","journal-title":"J Drugs Dermatol JDD."},{"issue":"11","key":"1053_CR46","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/j.1468-3083.2008.02807.x","volume":"22","author":"H Gollnick","year":"2008","unstructured":"Gollnick H, Luger T, Freytag S, Br\u00e4utigam M, STABIEL study group. StabiEL: stabilization of skin condition with Elidel\u2014a patients\u2019 satisfaction observational study addressing the treatment, with pimecrolimus cream, of atopic dermatitis pretreated with topical corticosteroid. J Eur Acad Dermatol Venereol. 2008;22(11):1319\u201325. https:\/\/doi.org\/10.1111\/j.1468-3083.2008.02807.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"1053_CR47","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1610-0387.2007.06609.x","volume":"6","author":"J Schmitt","year":"2008","unstructured":"Schmitt J, Cs\u00f6t\u00f6nyi F, Bauer A, Meurer M. Determinants of treatment goals and satisfaction of patients with atopic eczema. JDDG J Dtsch Dermatol Ges. 2008;6(6):458\u201365. https:\/\/doi.org\/10.1111\/j.1610-0387.2007.06609.x.","journal-title":"JDDG J Dtsch Dermatol Ges"},{"issue":"4","key":"1053_CR48","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/1346-8138.12094","volume":"40","author":"K Ito","year":"2013","unstructured":"Ito K, Imafuku S, Nakayama J. Therapeutic preferences are different in psoriatic and atopic dermatitis patients: a questionnaire-based study. J Dermatol. 2013;40(4):292\u20134. https:\/\/doi.org\/10.1111\/1346-8138.12094. (PubMed PMID: 23398234).","journal-title":"J Dermatol"},{"issue":"3","key":"1053_CR49","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.jaad.2020.01.044","volume":"83","author":"AM Bashyam","year":"2020","unstructured":"Bashyam AM, Cuellar-Barboza A, Ghamrawi RI, Feldman SR. Placebo tailoring improves patient satisfaction of treatment plans in atopic dermatitis. J Am Acad Dermatol. 2020;83(3):944\u20136. https:\/\/doi.org\/10.1016\/j.jaad.2020.01.044. (PubMed PMID: 32004644; PubMed Central PMCID: PMC8126996).","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"1053_CR50","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.socscimed.2009.08.036","volume":"69","author":"M Noerreslet","year":"2009","unstructured":"Noerreslet M, Jemec GBE, Traulsen JM. Involuntary autonomy: patients\u2019 perceptions of physicians, conventional medicines and risks in the management of atopic dermatitis. Soc Sci Med. 2009;69(9):1409\u201315. https:\/\/doi.org\/10.1016\/j.socscimed.2009.08.036.","journal-title":"Soc Sci Med"},{"issue":"4","key":"1053_CR51","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/bjd.17929","volume":"181","author":"P Maghen","year":"2019","unstructured":"Maghen P, Unrue EL, Oussedik E, Cline A, Cardwell LA, Feldman SR. Regardless of how risks are framed, patients seem hesitant to use topical steroids for atopic dermatitis. Br J Dermatol. 2019;181(4):842\u20134. https:\/\/doi.org\/10.1111\/bjd.17929. (PubMed PMID: 30916382).","journal-title":"Br J Dermatol"},{"issue":"3","key":"1053_CR52","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1177\/1203475420908250","volume":"24","author":"V Johnson Girard","year":"2020","unstructured":"Johnson Girard V, Hill A, Glaser E, Lussier MT. Optimizing communication about topical corticosteroids: a quality improvement study. J Cutan Med Surg. 2020;24(3):240\u20138. https:\/\/doi.org\/10.1177\/1203475420908250. (PubMed PMID: 32073313).","journal-title":"J Cutan Med Surg"},{"issue":"4","key":"1053_CR53","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1080\/09546634.2016.1230177","volume":"28","author":"H Jin","year":"2017","unstructured":"Jin H, Kim JM, Kim GW, Kim HS, Ko HC, Kim MB, et al. Inappropriate amounts of topical tacrolimus applied on Korean patients with eczema. J Dermatol Treat. 2017;28(4):327\u201331. https:\/\/doi.org\/10.1080\/09546634.2016.1230177. (PubMed PMID: 27588441).","journal-title":"J Dermatol Treat"},{"issue":"4","key":"1053_CR54","first-page":"324","volume":"9","author":"BA Yentzer","year":"2010","unstructured":"Yentzer BA, Camacho FT, Young T, Fountain JM, Clark AR, Feldman SR. Good adherence and early efficacy using desonide hydrogel for atopic dermatitis: results from a program addressing patient compliance. J Drugs Dermatol JDD. 2010;9(4):324\u20139 (PubMed PMID: 20514788).","journal-title":"J Drugs Dermatol JDD."},{"issue":"6","key":"1053_CR55","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/all.13712","volume":"74","author":"T Nakahara","year":"2019","unstructured":"Nakahara T, Fujita H, Arima K, Taguchi Y, Motoyama S, Furue M. Treatment satisfaction in atopic dermatitis relates to patient-reported severity: a cross-sectional study. Allergy. 2019;74(6):1179\u201381. https:\/\/doi.org\/10.1111\/all.13712. (PubMed PMID: 30593669).","journal-title":"Allergy"},{"issue":"5","key":"1053_CR56","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1159\/000508771","volume":"236","author":"S Madsen","year":"2020","unstructured":"Madsen S, Price KN, Shi VY, Lio PA. Pearls in mitigating application pain of topical nonsteroidal agents. Dermatol Basel Switz. 2020;236(5):477\u201380. https:\/\/doi.org\/10.1159\/000508771. (PubMed PMID: 32659770).","journal-title":"Dermatol Basel Switz."},{"issue":"7","key":"1053_CR57","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1080\/09546634.2017.1306017","volume":"28","author":"SD Smith","year":"2017","unstructured":"Smith SD, Farrugia LL, Harris V, Lee A, Carter SR, Blaszczynski A, et al. Evaluation of the influence of family and friends, and the Internet on patient perceptions of long-term topical corticosteroid use. J Dermatol Treat. 2017;28(7):642\u20136. https:\/\/doi.org\/10.1080\/09546634.2017.1306017. (PubMed PMID: 28349719).","journal-title":"J Dermatol Treat"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-026-01053-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-026-01053-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-026-01053-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T09:31:48Z","timestamp":1789464708000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-026-01053-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1053"],"URL":"https:\/\/doi.org\/10.1007\/s40257-026-01053-y","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"29 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"VYS is on the board of directors for the Hidradenitis Suppurativa Foundation (HSF), an advisor for the National Eczema Association, is a stock shareholder of Learn Health and has served as an advisory board member, investigator, speaker, and\/or received research funding from Sanofi Genzyme, Regeneron, AbbVie, ZuraBio, Genentech, Eli Lilly, Novartis, SUN Pharma, LEO Pharma, Pfizer, Incyte, Dermavant, Apogee, Boehringer Ingelheim, Almirall, Alumis, Aristea Therapeutics, Menlo Therapeutics, Dermira, Burt\u2019s Bees, Galderma, Kiniksa, UCB, Ceraclere, Target-PharmaSolutions, Castle Bioscience, Altus Lab\/cQuell, MYOR, Polyfins Technology, GpSkin and Skin Actives Scientific, Oruka, Insmed, Arcutis and Takeda. JLH is on the board of directors for the HS Foundation, and has served as an advisor, investigator, and\/or speaker for AbbVie, Amgen, Aclaris, AstraZeneca, Boehringer Ingelheim, Galderma, Incyte, Insmed, Leo Pharma, Moonlake, Navigator Medicines, Novartis, Oruka Therapeutics, Pfizer, Sanofi, Regeneron, UCB. CRM has served as an advisory board member for Oruka Therapeutics. AJ, SG, CBD, & LG have no disclosures.","order":1,"name":"Ethics","label":"Conflicts of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","label":"Funding","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data supporting the findings of this study are available within this article and its Supplementary Information.","order":7,"name":"Ethics","label":"Data Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors contributed to the study conception and design. Material preparation, systematic literature review, and analysis were performed by AJ, SG, & CBD. The manuscript was written and prepared by AJ, SG, CRM, & LG. All authors read and approved the final manuscript.","order":8,"name":"Ethics","label":"Author Contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}